VIRIDIAN THERAPEUTICS INC (VRDN)
US92790C1045 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -218.12M | -237.73M | -129.87M | -79.41M | -110.72M | |||
| Depreciation Amortization | 557.00K | 522.00K | 260.00K | 120.00K | 240.00K | |||
| Change In Working Capital | -8.12M | -9.43M | 15.96M | 1.72M | 4.43M | |||
| Interest Paid | N/A | 886.00K | 290.00K | 0.00 | 270.00K | |||
| Other non cash items | 58.26M | 62.47M | 19.82M | 22.99M | 76.27M | |||
| OPERATING CASH FLOW | -167.42M | -184.17M | -93.84M | -54.58M | -29.78M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -778.00K | -898.00K | -800.00K | -340.00K | -40.00K | |||
| Other Investing Activity | -223.22M | -93.35M | -114.33M | -73.95M | -50.44M | |||
| INVESTING CASH FLOW | -224.00M | -94.25M | -115.13M | -74.29M | -50.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 15.00M | 4.55M | 0.00 | -8.57M | |||
| Stock Issued/Repurchased | 396.72M | 217.82M | 336.58M | 132.22M | 111.23M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | -7.15M | -18.89M | -6.95M | -1.35M | |||
| FINANCING CASH FLOW | 394.55M | 225.67M | 322.24M | 125.28M | 101.31M | |||
| CHANGE IN CASH | 3.13M | -52.75M | 113.27M | -3.59M | 21.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -167.42M | -184.17M | -93.84M | -54.58M | -29.78M | |||
| Capital Expenditure | -778.00K | -898.00K | -800.00K | -340.00K | -40.00K | |||
| FREE CASH FLOW | -168.20M | -185.07M | -94.64M | -54.92M | -29.82M | |||
All data in USD